Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Milk and yogurt may fight inflammation in overweight adults

NCT ID NCT04902417

Disease control Sponsor: York University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether eating more dairy products for 6 weeks could lower inflammation and other signs of heart disease in overweight adults. Thirty-two people with low dairy intake and at least two other risk factors (like high blood pressure or blood sugar) took part. Researchers measured inflammation and blood fats before and after a high-fat meal to see if dairy made a difference.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

32 people

The number who actually took part.

Started

May 2022

Finished

Dec 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 70 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Body mass index (BMI) ≥ 25 kg/m2 * ≤ 2 structured exercise sessions/week * Habitual low dairy consumption (≤ 1 serving/day) * Having at least two other metabolic risk factors based on clinical guidelines: * Elevated blood pressure (≥130/≥85 mm Hg) * Impaired fasting glucose (≥5.6 mmol/L) measured using a finger prick sample * Impaired fasting triglycerides (≥1.7 mmol/L) or high-density lipoprotein (\<1.03 mmol/L for males, \<1.3 mmol/L for females) measured using a finger prick blood sample. * Increased waist circumference (≥102 cm for males and ≥88 cm for females). * Borderline high fasting low-density lipoprotein (≥3.5 mmol/L) or total cholesterol (≥5.2 mmol/L). Exclusion Criteria: * Allergy to dairy foods, diagnosed lactose intolerance or an aversion to foods provided during the study * Previous history of diabetes and/or related cardiovascular disease * The use of multiple medications for managing lipids, glucose and/or blood pressure

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cardiometabolic risk are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Inflammation inflammatory disease Obesity obesity disorder Overweight

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cardiometabolic risk Inflammation Overweight and obesity

Contacts and locations

Locations

  • York University

    Toronto, Ontario, M3J 1P3, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.